For melanoma, it could be shown that PTEN-deficient cells encourage a resistance to immune infiltration by increased levels of cytokines, such as VEGFR and CCL2, resulting in an immunosuppressive tumor microenvironment [84, 85]. Here, CCL2 is linked to neoplasm.